Literature DB >> 24986697

Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?

Eva Maria Fallenberg1, Clarisse Dromain, Felix Diekmann, Diane M Renz, Heba Amer, Barbara Ingold-Heppner, Avidan U Neumann, Klaus J Winzer, Ulrich Bick, Bernd Hamm, Florian Engelken.   

Abstract

The purpose of this study was to compare contrast-enhanced spectral mammography (CESM) with mammography (MG) and combined CESM + MG in terms of detection and size estimation of histologically proven breast cancers in order to assess the potential to reduce radiation exposure. A total of 118 patients underwent MG and CESM and had final histological results. CESM was performed as a bilateral examination starting 2 min after injection of iodinated contrast medium. Three independent blinded radiologists read the CESM, MG, and CESM + MG images with an interval of at least 4 weeks to avoid case memorization. Sensitivity and size measurement correlation and differences were calculated, average glandular dose (AGD) levels were compared, and breast densities were reported. Fisher's exact and Wilcoxon tests were performed. A total of 107 imaging pairs were available for analysis. Densities were ACR1: 2, ACR2: 45, ACR3: 42, and ACR4: 18. Mean AGD was 1.89 mGy for CESM alone, 1.78 mGy for MG, and 3.67 mGy for the combination. In very dense breasts, AGD of CESM was significantly lower than MG. Sensitivity across readers was 77.9 % for MG alone, 94.7 % for CESM, and 95 % for CESM + MG. Average tumor size measurement error compared to postsurgical pathology was -0.6 mm for MG, +0.6 mm for CESM, and +4.5 mm for CESM + MG (p < 0.001 for CESM + MG vs. both modalities). CESM alone has the same sensitivity and better size assessment as CESM + MG and was significantly better than MG with only 6.2 % increase in AGD. The combination of CESM + MG led to systematic size overestimation. When a CESM examination is planned, additional MG can be avoided, with the possibility of saving up to 61 % of radiation dose, especially in patients with dense breasts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24986697     DOI: 10.1007/s10549-014-3023-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  22 in total

1.  Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.

Authors:  Eva M Fallenberg; Florian F Schmitzberger; Heba Amer; Barbara Ingold-Heppner; Corinne Balleyguier; Felix Diekmann; Florian Engelken; Ritse M Mann; Diane M Renz; Ulrich Bick; Bernd Hamm; Clarisse Dromain
Journal:  Eur Radiol       Date:  2016-11-28       Impact factor: 5.315

2.  Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer.

Authors:  Janice S Sung; Lizza Lebron; Delia Keating; Donna D'Alessio; Christopher E Comstock; Carol H Lee; Malcolm C Pike; Miranda Ayhan; Chaya S Moskowitz; Elizabeth A Morris; Maxine S Jochelson
Journal:  Radiology       Date:  2019-08-27       Impact factor: 11.105

Review 3.  Contrast-enhanced mammography: past, present, and future.

Authors:  Julie Sogani; Victoria L Mango; Delia Keating; Janice S Sung; Maxine S Jochelson
Journal:  Clin Imaging       Date:  2020-09-19       Impact factor: 1.605

4.  The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.

Authors:  Sudan Tang; Chunhong Xiang; Quan Yang
Journal:  Br J Radiol       Date:  2020-07-02       Impact factor: 3.039

Review 5.  Contrast-enhanced Mammography: State of the Art.

Authors:  Maxine S Jochelson; Marc B I Lobbes
Journal:  Radiology       Date:  2021-03-02       Impact factor: 11.105

6.  Radiomics and Artificial Intelligence Analysis with Textural Metrics Extracted by Contrast-Enhanced Mammography in the Breast Lesions Classification.

Authors:  Roberta Fusco; Adele Piccirillo; Mario Sansone; Vincenza Granata; Maria Rosaria Rubulotta; Teresa Petrosino; Maria Luisa Barretta; Paolo Vallone; Raimondo Di Giacomo; Emanuela Esposito; Maurizio Di Bonito; Antonella Petrillo
Journal:  Diagnostics (Basel)       Date:  2021-04-30

7.  Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria.

Authors:  U C Lalji; C R L P N Jeukens; I Houben; P J Nelemans; R E van Engen; E van Wylick; R G H Beets-Tan; J E Wildberger; L E Paulis; M B I Lobbes
Journal:  Eur Radiol       Date:  2015-03-27       Impact factor: 5.315

Review 8.  Molecular imaging of breast cancer: present and future directions.

Authors:  David Alcantara; Manuel Pernia Leal; Irene García-Bocanegra; Maria L García-Martín
Journal:  Front Chem       Date:  2014-12-18       Impact factor: 5.221

Review 9.  The Changing World of Breast Cancer: A Radiologist's Perspective.

Authors:  Christiane K Kuhl
Journal:  Invest Radiol       Date:  2015-09       Impact factor: 6.016

10.  Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study.

Authors:  U C Lalji; I P L Houben; R Prevos; S Gommers; M van Goethem; S Vanwetswinkel; R Pijnappel; R Steeman; C Frotscher; W Mok; P Nelemans; M L Smidt; R G Beets-Tan; J E Wildberger; M B I Lobbes
Journal:  Eur Radiol       Date:  2016-04-20       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.